Clinical Evidence Human Trials: A randomized, placebo-controlled study in obese adults demonstrated that AOD-9604 significantly reduced abdominal and total body fat over several weeks of treatment, without serious side effects Animal Studies: Preclinical studies in mice and rats showed that AOD-9604: Stimulated lipolysis Inhibited lipogenesis (formation of new fat) Prevented weight gain despite high-fat diets This dual actionenhancing fat breakdown and inhibiting fat formationpositions AOD-9604 as a potent tool for combating obesity
GHK-Cu stimulates collagen and glycosaminoglycan synthesis, modulates inflammation, promotes angiogenesis, and supports tissue regeneration and repair
Your provider can explain which format is appropriate
Megaloblastic anemia due to vitamin B12 deficiency A fast heart rate may be a symptom of vitamin B12 deficiency
Certain medicationsincluding proton pump inhibitors, metformin, and some anticonvulsantsmay affect the absorption or metabolism of specific nutrients
AOD9604 was first synthesized in the 1990s and is supplied as a white to off-white lyophilized (freeze-dried) powder that is readily soluble in water